Cited by 360Extracellular vesicles in diseaseCellular transport and secretionHER2/EGFR in Cancer Research

Amphiregulin exosomes increase cancer cell invasion

Open access
Higginbotham, James N., Demory Beckler, Michelle, Gephart, Jonathan D., Franklin, Jeffrey L., Bogatcheva, Galina, Kremers, Gert-Jan, Piston, David W., Ayers, Gregory D. +3 more·2011·Current Biology

Abstract

Autocrine, paracrine, and juxtacrine are recognized modes of action for mammalian EGFR ligands including EGF, TGF-α (TGFα), amphiregulin (AREG), heparin-binding EGF-like growth factor (HB-EGF), betacellulin, epiregulin, and epigen. We identify a new mode of EGFR ligand signaling via exosomes. Human breast and colorectal cancer cells release exosomes containing full-length, signaling-competent EGFR ligands. Exosomes isolated from MDCK cells expressing individual full-length EGFR ligands displayed differential activities; AREG exosomes increased invasiveness of recipient breast cancer cells 4-fold over TGFα or HB-EGF exosomes and 5-fold over equivalent amounts of recombinant AREG. Exosomal AREG displayed significantly greater membrane stability than TGFα or HB-EGF. An average of 24 AREG molecules are packaged within an individual exosome, and AREG exosomes are rapidly internalized by recipient cells. Whether the composition and behavior of exosomes differ between nontransformed and transformed cells is unknown. Exosomes from DLD-1 colon cancer cells with a mutant KRAS allele exhibited both higher AREG levels and greater invasive potential than exosomes from isogenically matched, nontransformed cells in which mutant KRAS was eliminated by homologous recombination. We speculate that EGFR ligand signaling via exosomes might contribute to diverse cancer phenomena such as field effect and priming of the metastatic niche.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cub.2011.03.043

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Breast cancer cells incubated with exosomes containing high levels of AREG show significantly enhanced invasiveness compared to low AREG exosomes or recombinant EGFR ligands.

    “Further, significantly enhanced levels of invasiveness are observed when breast cancer cells are incubated with exosomes containing high levels of AREG compared to incubation of cells with exosomes containing low levels of AREG or recombinant EGFR ligands (Higginbotham et al., 2011), suggesting a gain-of-function mode of EGFR signaling that might act in more distant environments.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Higginbotham, J. N., Demory Beckler, M., Gephart, J. D., Franklin, J. L., Bogatcheva, G., Kremers, G.-J., Piston, D. W., Ayers, G. D., McConnell, R. E., Tyska, M. J., & Coffey, R. J.
Affiliations
  • Vanderbilt University Medical Center (US)
  • Nashville VA Medical Center (US)
Corresponding author
Coffey, Robert J.
Venue
Current Biology
Publisher
Elsevier BV
Published
2011-05
Volume
21
Issue
9
Pages
779-786
ISSN
0960-9822 (ISSN-L)
OpenAlex
W2063508984
Cited by
360
References
32
Citations by year
2026: 6 · 2025: 13 · 2024: 15 · 2023: 17 · 2022: 22 · 2021: 19 · 2020: 37 · 2019: 27 · 2018: 28 · 2017: 27 · 2016: 37 · 2015: 39 · 2014: 22 · 2013: 21 · 2012: 20
FWCI
9.36
Type
journal article
Language
en
Open access
Locations
  • Current Biology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • U.S. Public Health Service (P50 95103)
  • National Cancer Institute (P30 CA 68485, CA46413, R25CA092043, P50CA095103, 1R25 CA92043, R01CA163563, R01CA046413, T32CA009582, P30CA068485)
  • National Institute of General Medical Sciences (GM72048, P20GM072048)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK058404, R01DK075555, DK075555, P30DK058404)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (T32HD007502)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
  • Health Sciences › Medicine › Oncology › HER2/EGFR in Cancer Research
Keywords
amphiregulin, exosomes, EGFR ligands, tumor invasion, transforming growth factor-alpha, HB-EGF, KRAS mutation, breast cancer, colorectal cancer, exosome internalization, metastatic niche, field effect
MeSH terms
Animals, Centrifugation, Dogs, Electrophoresis, Polyacrylamide Gel, Enzyme-Linked Immunosorbent Assay, Glycoproteins, Humans, Microscopy, Electron, Neoplasm Invasiveness, Immunoblotting, Signal Transduction, Transforming Growth Factor alpha, Intercellular Signaling Peptides and Proteins, Cell Line, Tumor, Exosomes, ErbB Receptors, EGF Family of Proteins, Heparin-binding EGF-like Growth Factor, Amphiregulin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review